Proof-of-concept study linking ex vivo sensitivity testing to neoadjuvant anthracycline-based chemotherapy response in breast cancer patients

We developed a functional ex vivo anthracycline-based sensitivity test. Surgical resection material of primary breast cancer (BC) was used to determine criteria for the ex vivo sensitivity assay based on morphology, proliferation and apoptosis. Subsequently, a proof-of-concept study was performed co...

Descripción completa

Detalles Bibliográficos
Autores principales: Ladan, Marjolijn M., Meijer, Titia G., Verkaik, Nicole S., de Monye, Cecile, Koppert, Linetta B., Oomen-de Hoop, Esther, van Deurzen, Carolien H. M., Kanaar, Roland, Nonnekens, Julie, van Gent, Dik C., Jager, Agnes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542784/
https://www.ncbi.nlm.nih.gov/pubmed/37777518
http://dx.doi.org/10.1038/s41523-023-00583-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542784/
https://www.ncbi.nlm.nih.gov/pubmed/37777518
http://dx.doi.org/10.1038/s41523-023-00583-6

Ejemplares similares